Dannielle Appelhans, CEO & President at Rubius Therapeutics, holds 20.00K shares in Generation Bio (Ticker: GBIO), holds 0.00 shares in Rubius Therapeutics (Ticker: RUBY). Most recently, Dannielle Appelhans Bought ― shares of Generation Bio on Dec 11, 2023 for an estimated value of 14.34K.

See the Hottest Stocks Based on Insider Trading >

Dannielle Appelhans
Rubius Therapeutics (RUBY)
CEO & President

Ranked #20,969 out of 99,024 Corporate Insiders

Profitable Transactions

2 out of 2 Profitable Transactions

Average Return

+113.00%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

GBIO

A breakdown of Dannielle Appelhans's holdings

See the Top Stocks by Insiders

Insider Roles

Generation Bio
(GBIO)

Director

Roles that Dannielle Appelhans holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Generation Bio
(GBIO)

Rating:Informative Buy

Date:Dec 06, 2023 - Today

Return:+120.40%

The most profitable trade made by Dannielle Appelhans

See the Latest Stocks Traded by Insiders

Dannielle Appelhans's Trading History

RUBY

Rubius Therapeutics

Feb 27, 2023

―

Informative Sell

1.25K

$0.00

GBIO

Generation Bio

Dec 11, 2023

Director

Informative Buy

14.34K

$73.20K

List of latest transactions for each holding click on a transaction to see Dannielle Appelhans's performance on stock

See All Insider Trading from Today

Dannielle Appelhans insider profile FAQ

What is the percentage of profitable transactions made by Dannielle Appelhans?

The percentage of profitable transactions made by Dannielle Appelhans is 100%.

What is the average return per transaction made by Dannielle Appelhans?

The average return per transaction made by Dannielle Appelhans is 113.00%.

What stocks does Dannielle Appelhans hold?

Dannielle Appelhans holds: RUBY, GBIO stocks.

What was Dannielle Appelhans’s latest transaction?

Dannielle Appelhans latest transaction was an Informative Buy of $14.34K.

What was Dannielle Appelhans's most profitable transaction?

Dannielle Appelhans’s most profitable transaction was an Informative Buy of GBIO stock on December 6, 2023. The return on the trade was 120.40%.

What is Dannielle Appelhans's role in Rubius Therapeutics?

Dannielle Appelhans's role in Rubius Therapeutics is CEO & President.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Dannielle Appelhans Insider Profile

Dannielle Appelhans Rubius Therapeutics (RUBY)CEO & President